Tripterygium hypoglaucum
What's the taxonomical classification of Tripterygium hypoglaucum?
Tripterygium hypoglaucum belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it falls under the order Celastrales. Within this order, the plant is situated in the family Celastraceae. Its taxonomic hierarchy is completed by its placement in the genus Tripterygium, specifically identifying it as the species hypoglaucum.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Celastrales |
| Family | Celastraceae |
| Genus | Tripterygium |
| Species | hypoglaucum |
What are the morphological characteristics of this plant?
Tripterygium hypoglaucum has trifoliate leaves composed of three distinct leaflets that are typically ovate to lanceolate in shape and possess finely serrated margins. The foliage is characterized by a deep green upper surface and a noticeably paler, sometimes slightly glaucous underside. Its stems are woody climbers that utilize twining mechanisms to ascend surrounding vegetation. During its flowering period, the plant produces small, inconspicuous yellowish-green flowers arranged in dense panicles. The reproductive structures eventually develop into winged samaras that facilitate wind dispersal of the seeds.
What is the geographical distribution of this plant?
This plant is native to the temperate and subtropical regions of East Asia, specifically ranging across parts of China, Japan, and the Korean Peninsula. Within these regions, it typically inhabits moist, shaded environments such as forest understories and mountainous terrain. Its distribution is often tied to specific elevational gradients where humidity and soil moisture remain consistent. Local populations can be found in diverse habitats ranging from deciduous woodlands to riparian zones. The species relies on these particular microclimates to support its climbing growth habit and seasonal life cycle.
How is this plant cultivated?
This plant requires well-drained, humus-rich soil and a location that provides partial shade to protect its climbing vines from intense midday sunlight.
Because it is a vigorous woody climber, it needs a sturdy trellis or support structure to facilitate its upward growth. Regular watering is essential to maintain consistent soil moisture, especially during the warmer summer months. Once established, the plant is relatively hardy and can tolerate various temperate climates if given adequate space to spread.
Proper pruning should be performed annually to manage its rapid expansion and encourage healthy foliage development.
What parts of this plant are used medicinally?
This plant Tripterygium hypoglaucum utilizes its rhizome, root, shoots, stems, and fruit for various medicinal purposes. The dried rhizome and root are the most commonly harvested parts used in traditional formulas to treat inflammation and pain. Medicinal preparations also incorporate the shoots and stems to harness specific bioactive compounds found in the vascular structure. Additionally, the fruit is sometimes processed for its unique chemical properties in specialized herbal remedies. These diverse components collectively contribute to the plant's therapeutic profile in traditional medicine.
According to a study published by "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", the rhizome of Tripterygium hypoglaucum (Lévl.) Hutch is mainly used in clinical settings for treating autoimmune diseases like rheumatoid arthritis. A total of 4 active compounds were isolated from the THH methanol extract. HPLC results showed that the proportions of the active ingredients celastrol, triptolide, and 3-O-acetyloleanolic acid in THH-MeOH were 0.79 ‰, 0.46 ‰, and 0.76 ‰, respectively. The THH-MeOH extract attenuates psoriasis-like lesions by inhibiting cellular hyperproliferation and modulating immune responses. This work provides a theoretical basis to support using THH for treating psoriasis.
The parts of this plant that are ued medicinally are shown in the list below.
- rhizome
- root
- shoots
- stems
- fruit
What traditional systems uses this plant?
This plant, known as Lei Gong Teng, has been utilized for centuries within Traditional Chinese Medicine to treat conditions such as rheumatoid arthritis, epilepsy, and various skin ailments. Practitioners historically prepared the dried vine to clear heat and resolve wind, aiming to alleviate pain and numbness in the limbs. The botanical components were often decocted into teas or powders to address neurological symptoms and inflammatory issues. Beyond its primary use in Chinese herbology, the plant's historical applications reflect an early understanding of its potent pharmacological properties. These ancient methods laid the foundational knowledge that modern researchers now use to study its potential autoimmune benefits.
According to a study published by "Frontiers in pharmacology", Tripterygium hypoglaucum (Lévl.) Hutch (THH) is believed to play an important role in health care and disease treatment according to traditional Chinese medicine. This plant is considered a representative of medicine with both significant efficacy and potential toxicity. Phytochemical research has found more than 120 secondary metabolites in THH, including terpenoids, alkaloids, glycosides, sugars, organic acids, oleanolic acid, and polysaccharides. These components may serve as the pharmacological bases for immunosuppression, anti-inflammatory, and anti-tumour effects. Recent studies also found that THH and its bioactive compounds demonstrated remarkable effects on obesity, insulin resistance, fertility, and infection of virus.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Chinese Medicine
What are the pharmacological activities of Tripterygium hypoglaucum?
This plant has diverse pharmacological activities including anti-inflammatory, anti-rheumatic, anti-tumor, anti-cancer, and anti-viral properties. Its bioactive compounds work to reduce systemic inflammation and alleviate the painful symptoms associated with various rheumatic diseases. Researchers have also identified significant potential in its ability to inhibit the growth and spread of malignant cells through anti-tumor and anti-cancer mechanisms. Furthermore, the plant exhibits potent anti-viral characteristics that can help combat certain infectious pathogens. These multifaceted medicinal qualities make it a subject of intense interest in modern drug development.
According to a study published by "Virologica Sinica", Tripterygium hypoglaucum is a traditional Chinese medicine plant with pharmacological activities including anti-inflammation, anti-tumor, and antifertility. The roots of the plant contain about a 1% yield of alkaloids. An alkaloid extract from these roots showed low cytotoxicity with a CC50 of 46.6 μg/mL and a potent IC50 of 6.5 μg/mL against HSV-1. At concentrations of 6.25 μg/mL to 12.5 μg/mL, the plaque reduction ratio reached 55% to 75%, which was 35% higher than Acyclovir at the same concentration. At a working concentration of 12.5 μg/mL, the extract suppressed the expression of the UL30 gene by 74.6%, the UL39 gene by 70.9%, and the US6 gene by 62.6%.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
- anti-rheumatic
- anti-tumor
- anti-cancer
- anti-viral
What medicinal compounds this plant contains?
This plant contains the bioactive diterpenoid triptolide along with the specific alkaloids triptecumine A, triptecumine B, triptecumine C, and triptecumine D. These diverse chemical constituents are primarily studied for their significant immunosuppressive and anti-inflammatory properties. Researchers have focused on these compounds to develop potential treatments for autoimmune diseases and various types of cancer. The structural variations between the different triptecumine derivatives contribute to their unique pharmacological profiles. Understanding these medicinal components is essential for advancing modern drug discovery from natural sources.
According to a study published by "Frontiers in pharmacology", Tripterygium hypoglaucum (Lévl.) Hutch (THH) contains more than 120 secondary metabolites. These components include terpenoids, alkaloids, glycosides, sugars, organic acids, oleanolic acid, and polysaccharides. These compounds serve as the pharmacological bases for immunosuppression, anti-inflammatory, and anti-tumour effects. Additionally, the plant contains bioactive compounds like triptolide, which undergoes quick elimination, and celastrol. These medicinal components demonstrate effects on obesity, insulin resistance, fertility, and virus infection.
The primary medicinal compounds of this plant are shown in the list below.
- triptolide
- triptecumine A
- triptecumine B
- triptecumine C
- triptecumine D
What health conditions is this plant used for?
This plant is used for treating rheumatoid arthritis, psoriasis, general inflammation, various inflammatory diseases, and skin inflammation. It contains active compounds that help modulate the immune system to reduce painful swelling. These medicinal properties make it a common traditional remedy for managing chronic autoimmune responses. Specifically, it is often applied or ingested to soothe redness and irritation caused by dermatological conditions. Its ability to target systemic issues makes it valuable for a wide range of inflammatory disorders.
According to a study published by "Science China. Life sciences", Tripterygium hypoglaucum is a perennial vine shrub with medicinal uses in treating rheumatoid arthritis, cancer, and male contraception. Researchers identified 14 sesquiterpene synthase genes through mining multi-omics data of Tripterygium species. Among the bioactive ingredients are macrocyclic dihydroagarofuran sesquiterpene alkaloids, which are well-known for cytotoxicity and insecticidal properties. A group of enzymes including ThTPS5 catalyzes the key step committed to the biosynthesis of these alkaloids. Furthermore, the study notes that intensive phytochemical investigations have occurred over the last half-century.
The main health conditions this plant is used for are shown in the list below.
- rheumatoid arthritis
- psoriasis
- inflammation
- inflammatory diseases
- skin inflammation
What are the herbal preparations of this plant?
This plant is Tripterygium hypoglaucum, a medicinal herb used to create various therapeutic preparations such as THH extract, alkaloids, decoction pieces, and petroleum ether extracts. The active alkaloids found within the plant serve as the primary medicinal components for treating inflammatory conditions. Researchers often utilize petroleum ether extracts to isolate specific lipophilic compounds during the purification process. Additionally, traditional medicine frequently employs decoction pieces to prepare aqueous solutions for consumption. These diverse preparation methods allow for the controlled extraction of the plant's potent bioactive molecules.
According to a study published by "Journal of ethnopharmacology", Tripterygium hypoglaucum (levl.) Hutch (Celastraceae) (THH) root is a traditional Chinese medicinal herb used for treating cancer and autoimmune diseases. Total alkaloids of THH (THHta) were extracted in pilot-scale to evaluate antitumor properties. THHta significantly inhibited TPA-induced cell transformation in JB6 Cl41 cells and inhibited the growth of colon cancer cells in vitro in a significant dose-dependent manner. In a xenograft mouse model, i.p. administration of THHta significantly reduced both tumor weight and volume compared to the control set. THHta induced apoptosis by activating caspase-3 and PARP while inhibiting Bcl-2, Bcl-xL, and XIAP. This plant extract was effective in inhibiting tumor growth both in vitro and in vivo at less toxic concentrations.
The main herbal preparations of this plant are shown in the list below.
- THH extract
- alkaloids
- decoction pieces
- petroleum ether extracts
What side effects this plant can have?
This plant can cause severe health issues including aneuploidy of chromosome 8, antifertility, genital system toxicity, mutagenic effects, and tk locus mutation. These toxicological concerns arise from its ability to disrupt genetic stability and cellular processes within the body. Research indicates that exposure can lead to significant damage to the reproductive organs and overall fertility. Furthermore, the plant exhibits mutagenic properties that can trigger harmful mutations at the tk locus. Such genetic alterations pose a serious risk to long-term cellular health and biological function.
According to a study published by "Mutagenesis", Tripterygium hypoglaucum (level) Hutch induces aneuploidy of chromosome 8 in mouse bone marrow cells and sperm. Male mice received single i.p. injections of THH at doses of 120, 240, and 480 mg/kg. Trisomy 8 frequencies in bone marrow cells were 0.33%, 0.41%, and 0.41% in the THH-treated groups compared to 0.16% in the solvent control group. Disomy 8 sperm frequencies were 0.23%, 0.27%, and 0.27% in the THH-treated groups compared to 0.11% in the solvent control group. All groups were significantly different from the solvent controls with P < 0.01-0.001, although there was no dose-related increase. THH appears to be a potent mammalian aneugen that may pose a genetic risk to human patients.
The main side effects this plant can have are shown in the list below.
- aneuploidy of chromosome 8
- antifertility
- genital system toxicity
- mutagenic effects
- tk locus mutation
What herbs are paired with Tripterygium hypoglaucum?
This plant is traditionally paired with herbs such as angelica root, rehmannia, and peony root to enhance its medicinal efficacy in traditional formulas.
These combinations are often formulated to balance the plant's potent properties and target specific systemic issues like inflammation or blood circulation. Practitioners frequently include licorice root in these mixtures to harmonize the various ingredients and improve overall compatibility. Such pairings are carefully selected based on their synergistic effects on the body's energetic pathways.
By blending Tripterygium hypoglaucum with these complementary herbs, the therapeutic profile of the decoction is significantly broadened.